V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007370 | 310009721 | 1.56 | 60.5 | Palliative (P) | 2015-06-06 | 2015-06-07 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310017864 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007371 | 310004507 | 1.8 | 90.9 | null | null | 2018-02-10 | Methotrexate intrathecal | null | null | 310017875 | METHOTREXATE INTRATHECAL |
| 310007373 | 310004511 | null | 75.7 | Not known (9) | 2017-10-27 | 2018-06-02 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310017881 | CARBOPLATIN + ETOPOSIDE |
| 310007374 | 310004511 | 1.67 | 57.8 | Palliative (P) | 2013-08-26 | 2013-09-02 | CARBOPLATIN + ETOPOSIDE | N | N | 310017881 | UKALL2011 |
| 310007375 | 310004513 | 1.66 | 71 | Palliative (P) | 2013-01-18 | 2014-10-24 | ETOPOSIDE | N | N | 310017898 | ETOPOSIDE |
| 310007376 | 310007912 | 1.77 | 59.3 | Disease modification (D) | 2017-10-24 | 2017-10-26 | Rituximab | Y | null | 310017898 | RITUXIMAB |
| 310007377 | 310004516 | 1.73 | 82.8 | null | 2016-07-04 | 2016-07-12 | Docetaxel 100mg/m2 (21 day) | 02 | N | 310017905 | DOCETAXEL |
| 310007378 | 310004516 | 1.69 | null | Palliative (P) | null | 2016-12-16 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | Y | N | 310017905 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007379 | 310004517 | 1.69 | 32.8 | Curative (C) | 2016-07-15 | 2016-07-17 | Etoposide oral | 2 | Y | 310017909 | ETOPOSIDE |
| 310007380 | 310004518 | 1.71 | 83.3 | Curative (C) | 2014-09-13 | 2014-09-14 | Ipilimumab | N | N | 310017918 | IPILIMUMAB |
| 310007381 | 310004519 | 1.69 | null | Curative (C) | 2015-01-14 | 2015-01-14 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 310017922 | CISPLATIN + RT |
| 310007382 | 310004519 | 1.69 | null | Palliative (P) | 2013-12-10 | 2014-01-01 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310017922 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007383 | 310004521 | 1.57 | 22.4 | null | 2018-04-27 | 2018-05-03 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310017932 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007384 | 310004522 | 1.71 | 36.7 | Palliative (P) | null | 2015-06-15 | Bexarotene | N | N | 310017935 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007385 | 310004522 | 1.7 | 69.5 | Curative (C) | 2016-02-24 | 2016-02-26 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 2 | N | 310017935 | DOCETAXEL + GEMCITABINE |
| 310007386 | 310004522 | 1.52 | 77.9 | Neo-adjuvant (N) | 2013-11-27 | 2013-12-16 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310017935 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007387 | 310004523 | 1.57 | 52.2 | Palliative (P) | 2018-06-14 | 2018-06-21 | Docetaxel + Gemcitabine with GCSF | 02 | N | 310017970 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007388 | 310004524 | 1.64 | 91 | Palliative (P) | 2017-02-17 | 2017-03-19 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 310017972 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007389 | 310004525 | 1.72 | 51 | Palliative (P) | 2014-09-07 | 2014-09-14 | Carboplatin + Etoposide iv&po | N | N | 310017972 | ESHAP |
| 310007390 | 310010692 | null | null | Curative (C) | 2017-04-24 | 2017-05-03 | Bevacizumab+Carbo+Pacliaxel | N | N | 310017977 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007391 | 310004526 | null | 55.2 | Neo-adjuvant (N) | 2017-05-12 | 2017-06-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310017978 | DOCETAXEL |
| 310007392 | 310004527 | 1.56 | 48.3 | Palliative (P) | 2015-04-25 | 2015-04-29 | Etoposide oral | 02 | null | 310017980 | ETOPOSIDE |
| 310007393 | 310009729 | 1.73 | null | Curative (C) | 2018-12-21 | 2018-12-21 | Cyclophosphamide High Dose | N | N | 310017984 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007394 | 310004529 | 1.58 | 66.8 | Curative (C) | 2013-07-28 | 2014-07-06 | Docetaxel+Gemcitabine (no prior RT) | N | N | 310018005 | DOCETAXEL + GEMCITABINE |
| 310007395 | 310004531 | 1.84 | 85.3 | Curative (C) | 2015-11-21 | 2016-02-17 | Cyclophosphamide oral | N | N | 310018008 | CYCLOPHOSPHAMIDE |
| 310007396 | 310004531 | 1.62 | 66 | Curative (C) | 2017-09-05 | 2017-09-06 | Cisplatin | N | N | 310018008 | CISPLATIN |
| 310007397 | 310009730 | 1.55 | 73 | Curative (C) | null | 2015-08-27 | Etoposide oral | 02 | null | 310018013 | ETOPOSIDE |
| 310007398 | 310004532 | 1.76 | 72.5 | Curative (C) | 2014-05-21 | 2014-05-29 | Ipilimumab | 02 | N | 310018014 | IPILIMUMAB |
| 310007399 | 310004532 | 1.8 | 59.8 | Curative (C) | 2016-01-15 | 2016-11-12 | Carboplatin + Etoposide IV 3 day | N | N | 310018014 | UKALL2011 |
| 310007400 | 310004535 | 1.69 | 78.7 | Curative (C) | 2016-06-16 | 2017-06-26 | Cisplatin + Radiotherapy | N | N | 310018023 | CISPLATIN + RT |
| 310007401 | 310004536 | 1.68 | 54.9 | Curative (C) | 2017-06-27 | 2017-07-17 | Rituximab | 02 | N | 310018037 | RITUXIMAB |
| 310007402 | 310004539 | 1.52 | 66 | null | 2018-01-29 | 2018-02-02 | CHOP R - 21 days | N | N | 310018039 | CHOP R |
| 310007403 | 310004540 | 1.61 | 50.3 | Curative (C) | 2017-12-18 | 2017-12-19 | Bexarotene | N | N | 310018046 | UKALL2011 |
| 310007404 | 310004544 | 1.79 | 90.5 | Curative (C) | 2017-06-17 | 2017-06-20 | Cisplatin + Radiotherapy | 02 | N | 310018047 | CISPLATIN + RT |
| 310007405 | 310004544 | 1.6 | 59 | Palliative (P) | 2013-08-21 | 2013-08-24 | Bexarotene | Y | N | 310018047 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007406 | 310004545 | 1.68 | null | Curative (C) | 2015-12-14 | 2015-12-15 | CARBOPLATIN + ETOPOSIDE | 02 | N | 310018063 | BEXAROTENE |
| 310007407 | 310007926 | 1.65 | 72.6 | Neo-adjuvant (N) | 2016-07-16 | 2016-07-16 | Etoposide oral | 02 | N | 310018064 | ETOPOSIDE |
| 310007408 | 310007926 | 1.63 | 67 | Curative (C) | 2014-11-28 | 2015-12-10 | Cyclophosphamide High Dose | 02 | N | 310018064 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007409 | 310009732 | 1.73 | 68.3 | Adjuvant (A) | 2015-10-18 | 2015-11-15 | ALL UKALL2011 Aug BFM Cons C PegAsp | N | N | 310018077 | CARBOPLATIN + ETOPOSIDE |
| 310007410 | 310009732 | 0 | 136.3 | Neo-adjuvant (N) | 2018-05-26 | 2018-06-03 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310018077 | UKALL2011 |
| 310007411 | 310009732 | 0 | 54 | Curative (C) | 2017-06-22 | 2017-08-03 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 310018077 | CISPLATIN + RT |
| 310007414 | 310004552 | 1.76 | 68 | Palliative (P) | 2015-07-06 | 2015-11-23 | Ipilimumab | N | N | 310018091 | IPILIMUMAB |
| 310007415 | 310004553 | 1.58 | 50.6 | Palliative (P) | 2014-11-29 | 2015-02-11 | Docetaxel 75mg/m2 (21 day) | N | N | 310018095 | DOCETAXEL |
| 310007416 | 310004553 | 0 | 66 | Palliative (P) | 2017-08-11 | 2017-09-26 | ETOPOSIDE | N | null | 310018095 | ETOPOSIDE |
| 310007417 | 310007932 | 1.96 | null | Palliative (P) | 2016-01-12 | 2016-01-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310018110 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007418 | 310004556 | 1.81 | 81.8 | Disease modification (D) | 2014-12-21 | 2015-02-10 | Rituximab | N | N | 310018115 | RITUXIMAB |
| 310007419 | 310007933 | 1.6 | 75 | Curative (C) | null | 2016-07-25 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 310018115 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007420 | 310009736 | 1.72 | 72 | null | null | 2016-01-27 | Rituximab | N | N | 310018124 | RITUXIMAB |
| 310007421 | 310004560 | 1.56 | 52.1 | Curative (C) | 2017-12-20 | 2017-12-20 | CHOP R - 21 days | 02 | N | 310018125 | CHOP R |
| 310007422 | 310004562 | 1.9 | 73 | Disease modification (D) | null | 2017-02-15 | GDP | N | N | 310018127 | GDP |